Nuveen Asset Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $20.7M | Buy |
473,728
+14,391
| +3% | +$629K | 0.01% | 1177 |
|
|
2024
Q3 | $20.8M | Buy |
459,337
+4,205
| +0.9% | +$191K | 0.01% | 1167 |
|
|
2024
Q2 | $17.7M | Buy |
455,132
+81,357
| +22% | +$3.16M | 0.01% | 1214 |
|
|
2024
Q1 | $12M | Sell |
373,775
-10,893
| -3% | -$351K | ﹤0.01% | 1488 |
|
|
2023
Q4 | $11M | Buy |
384,668
+109,723
| +40% | +$3.15M | ﹤0.01% | 1529 |
|
|
2023
Q3 | $7.61M | Sell |
274,945
-2,445
| -0.9% | -$67.7K | ﹤0.01% | 1632 |
|
|
2023
Q2 | $7.42M | Buy |
277,390
+38,569
| +16% | +$1.03M | ﹤0.01% | 1676 |
|
|
2023
Q1 | $5.17M | Buy |
238,821
+37,669
| +19% | +$816K | ﹤0.01% | 1868 |
|
|
2022
Q4 | $4.79M | Sell |
201,152
-30,952
| -13% | -$737K | ﹤0.01% | 1928 |
|
|
2022
Q3 | $4.58M | Buy |
232,104
+20,612
| +10% | +$406K | ﹤0.01% | 1956 |
|
|
2022
Q2 | $4.12M | Buy |
211,492
+2,524
| +1% | +$49.2K | ﹤0.01% | 2071 |
|
|
2022
Q1 | $4.34M | Sell |
208,968
-7,149
| -3% | -$148K | ﹤0.01% | 2137 |
|
|
2021
Q4 | $5.44M | Sell |
216,117
-126,158
| -37% | -$3.18M | ﹤0.01% | 2068 |
|
|
2021
Q3 | $9.42M | Sell |
342,275
-27,705
| -7% | -$762K | ﹤0.01% | 1824 |
|
|
2021
Q2 | $11.7M | Buy |
369,980
+162,602
| +78% | +$5.16M | ﹤0.01% | 1761 |
|
|
2021
Q1 | $9.52M | Buy |
207,378
+54,518
| +36% | +$2.5M | ﹤0.01% | 1829 |
|
|
2020
Q4 | $6.05M | Buy |
152,860
+713
| +0.5% | +$28.2K | ﹤0.01% | 1971 |
|
|
2020
Q3 | $5.29M | Buy |
152,147
+23,210
| +18% | +$808K | ﹤0.01% | 1885 |
|
|
2020
Q2 | $4.07M | Buy |
128,937
+48,352
| +60% | +$1.53M | ﹤0.01% | 2013 |
|
|
2020
Q1 | $1.77M | Buy |
+80,585
| New | +$1.77M | ﹤0.01% | 2248 |
|